Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07173049 · ClinicalTrials.gov registry record · NA

Speech Production Enhancement Using Augmentative Communication for Kids

A NA study, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
100
Enrollment target

NCT07173049 is a NA study that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07173049, a NA study, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if speech supplementation can improve speech intelligibility in children ages 7 to 17 years with cerebral palsy. The main questions it aims to answer are: * To what extent can speech supplementation improve intelligibility in children with CP compared with habitual speech produced without speech supplementation? * How much intelligibility change is necessary for meaningful improvement when children use speech supplementation strategies? Participants will: * complete speech and language assessments * complete a speech pre-test using habitual speech * learn a speech supplementation strategy with training from a speech-language pathologist * complete a speech post-test using the speech supplementation strategy * complete a speech repetition task where specific words are emphasized (emphatic stress) * use the previously learned speech supplementation strategy + emphasis on specific words while producing a set of sentences

Interventions

  • BEHAVIORAL AAC Speech supplementation

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-07
Est. Completion 2029-07
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT07173049

The ClinicalTrials.gov registry entry for NCT07173049 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which AAC Speech supplementation is the first listed.

NCT07173049 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07173049 about?

NCT07173049 is a clinical study titled "Speech Production Enhancement Using Augmentative Communication for Kids". The goal of this clinical trial is to learn if speech supplementation can improve speech intelligibility in children ages 7 to 17 years with cerebral palsy. The main questions it aims to answer are: * To what extent can speech supplementation improve intelligibility in children with CP compared wit...

What is the current status of trial NCT07173049?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2029-07.

What interventions are being tested in trial NCT07173049?

The interventions under investigation include: AAC Speech supplementation (BEHAVIORAL).

Who is sponsoring clinical trial NCT07173049?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.